Latest developments in OTC pain relief, eye care and more

Pharmacy customers are continually seeking the best possible health advice, so awareness of the latest therapeutic advances in key categories is essential. With the impact of codeine rescheduling still reverberating around the industry, this session will discuss the growing body of scientific evidence to support the OTC analgesic offerings available in pharmacy.

The session will also discuss dry eye disease, which is becoming an increasingly prevalent issue, and the latest developments in the rapidly evolving eye care sector. Exciting new product innovation in significant OTC categories will also be shared.

Speaker: Dr Hartley Atkinson, Pain Researcher & CEO, AFT Pharmaceuticals
When: 8.30am – 9.15am, Saturday 7 September

Proudly sponsored by:

View the program for more details.

 

Stay up to date with Pharmacy Connect 2019! 
Newsletter: Subscribe to the newsletter here
Facebook: Follow @PharmacyConnectConference
Twitter: Follow @PharmConnectAus